NIH-funded research R21 grant

Targeted nanoparticle therapy to help bone-and-muscle injuries heal

Official title: Targeted Drug Delivery Systems to Regenerate Muscle-Bone Composite Tissue Injuries

Funded at University of Oregon · NIH-11371812 · Data updated 2026-11-12

A корот plain-English sentence: researchers are testing tiny, targeted particles that deliver healing drugs directly to areas where bone and muscle are damaged to speed recovery after serious injuries.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Oregon
NIH-funded
Lab location1 site (Eugene, United States)
Project startSeptember 4, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$333,508
NIH project number1R21AR086419-01A1
Project IDNIH-11371812 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with acute composite bone-muscle injuries eligible for non-surgical or minimally invasive therapy as part of standard care.

Less likely to help

Patients with non-healing or chronic, non-regenerative injuries or those unable to receive nanoparticle-based therapy may not benefit.

What this research studies

This project tests a novel nanoparticle system that homes in on damaged tissue to deliver a drug that promotes healing of both bone and muscle. The work focuses on improving regeneration for composite injuries that occur after accidents, with the goal of reducing long-term disability and healthcare costs. The study builds on previous findings that TRAP-binding nanoparticles can target fracture sites and deliver a Wnt pathway activator to accelerate healing, using a high-risk, high-reward approach in an animal and early translational context.

Why it matters

Potential benefit: If successful, patients with complex bone-muscle injuries could heal faster and regain function sooner.

How similar studies have gone: Previous studies showed enhanced healing with targeted nanoparticles in fracture models, supporting potential benefit in multi-tissue injuries.

Where this research is happening

  • University of Oregon
    Eugene, United States
    Active

Researchers

  • Principal investigator: Benoit, Danielle S. — University of Oregon
  • Study coordinator: Benoit, Danielle S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.